Figures
Abstract
Introduction
Hypothermic machine perfusion offers great promise in kidney transplantation and experimental studies are needed to establish the optimal conditions for this to occur. Pig kidneys are considered to be a good model for this purpose and share many properties with human organs. However it is not established whether the metabolism of pig kidneys in such hypothermic hypoxic conditions is comparable to human organs.
Methods
Standard criteria human (n = 12) and porcine (n = 10) kidneys underwent HMP using the LifePort Kidney Transporter 1.0 (Organ Recovery Systems) using KPS-1 solution. Perfusate was sampled at 45 minutes and 4 hours of perfusion and metabolomic analysis performed using 1-D 1H-NMR spectroscopy.
Results
There was no inter-species difference in the number of metabolites identified. Of the 30 metabolites analysed, 16 (53.3%) were present in comparable concentrations in the pig and human kidney perfusates. The rate of change of concentration for 3-Hydroxybutyrate was greater for human kidneys (p<0.001). For the other 29 metabolites (96.7%), there was no difference in the rate of change of concentration between pig and human samples.
Citation: Nath J, Guy A, Smith TB, Cobbold M, Inston NG, Hodson J, et al. (2014) Metabolomic Perfusate Analysis during Kidney Machine Perfusion: The Pig Provides an Appropriate Model for Human Studies. PLoS ONE 9(12): e114818. https://doi.org/10.1371/journal.pone.0114818
Editor: Helge Bruns, University Hospital Oldenburg, Germany
Received: June 30, 2014; Accepted: October 21, 2014; Published: December 12, 2014
Copyright: © 2014 Nath et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: The authors confirm that, for approved reasons, some access restrictions apply to the data underlying the findings. Data are available at Dryad: doi:10.5061/dryad.9jc16.
Funding: University Hospital Birmingham Charities £60,000 Grant number Dkaarcde17496. Organ Recovery Systems, Donation of Lifeport machine (value circa £25,000).
Competing interests: Mark Cobbold is a PLOS ONE Editorial board member. This does not alter the authors' adherence to PLOS ONE Editorial policies and criteria.
Introduction
The use of Hypothermic Machine Perfusion (HMP) in the period between kidney retrieval and implantation is supported by robust clinical evidence with improved early graft outcome [1]–[9]. Flow dynamics during perfusion is likely to account for some of the benefits of HMP, with reduced intra-renal resistance (and therefore increased flow) a marker of good graft function [10]–[12]. However, the exact mechanism by which HMP improves outcome remains unclear and there is likely to be a metabolic component underlying these beneficial effects [13], [14]. Accordingly, improved metabolic support during perfusion becomes a target for graft optimisation. Experimental studies are needed to clarify these mechanisms and optimisation of preservation may lead to improved transplant outcomes, especially in marginal kidneys. However the metabolic activity in this ex vivo, hypoxic, hypothermic environment is poorly understood.
Metabolomic analysis using 1H NMR spectroscopy permits identification and quantification of a large number of metabolites within a biological sample and is the subject of great interest. Easy access to perfusate during HMP and ability to perform serial measurements render this an attractive technique with which to establish a reliable biomarker and may even provide the option to improve the metabolic function of organs with obvious potential benefits. We have shown that perfusate analysis of human cadaveric kidneys is feasible and can be used to reliably predict post transplant graft function [15]
Porcine kidneys are a convenient and accessible animal model for experimental studies. They are readily available and have comparable size and physiological properties to human organs [16]–[19]. Within transplantation, porcine models have been studied extensively and normothermic perfusion is a good example of how this has translated into clinical practice [20]. On a functional level, analysis using 1H-NMR spectroscopy of perfusate from autotransplanted pig kidneys has demonstrated that metabolite concentrations do correspond to graft outcome indicating that there is a strong correlation between pre-transplant metabolism and graft function [21].
Under normal physiological conditions, the metabolic profiles of porcine blood, kidney tissue, urine and serum have been shown to be comparable to humans [22], [23]. As of yet, this has not been validated in the ex vivo hypothermic environment as encountered during HMP. The aim of this study is to compare the metabolic profile of human and porcine kidneys using 1H-NMR spectroscopy of HMP-derived perfusate to determine whether the porcine model is a valid surrogate for human studies.
Methods
Human subject research
Ethical approval was obtained from the West of Scotland Research Ethics Service for collection of human perfusate samples and subsequent NMR analysis (REC reference number: 12/WS/0166). Written consent for research purposes was granted from donor next of kin and from prospective kidney recipients to allow for collection and publication of postoperative transplant function information.
Animal Research
Abattoir/slaughterhouse pig kidneys were used in this study, acquired through F.A. Gill, Wolverhampton. No animals were sacrificed solely for the purposes of this study and therefore no ethical board approval was necessary.
Human studies
Standard criteria (e.g. donor age <60) adult cadaveric kidneys (n = 12) accepted for transplantation and undergoing HMP at the Queen Elizabeth Hospital, Birmingham between July 2012 and August 2013 were included, subject to consent and resource availability. Kidneys from DCD (Donation after Cardiac Death) donors and those fulfilling standard criteria definitions but with predicted delayed graft function (e.g. Cold ischaemia time >16 hours) were excluded to enable valid comparison with the pig group.
Organs were cold stored at 4°C in the period following retrieval according to local retrieval team protocols and transferred to the perfusion machine at the host centre. Decision to preserve organs with HMP was determined by centre policy.
Pig studies
Experiments were performed on 22–26 week old ‘bacon weight’ pigs, weighing 80–85 kg (n = 10). All experiments were performed following the principles of laboratory animal care according to NIH standards. Animal were sacrificed by electrical stunning and exsanguination. Cold perfusion was performed ex-vivo following laparotomy and retrieval and occurred within 14 minutes of death. Kidneys were initially cold flushed (4°C) with 1L Soltran solution under aseptic conditions at pressure of 150 mmHg. Organs were then cold stored in KPS-1 solution for two hours prior to machine perfusion to replicate human organ cold storage conditions.
Hypothermic Machine Perfusion
Perfusion pressure for both animal and human organs was set at 30 mmHg and kidneys were perfused with 1 L of KPS-1 at 4°C using LifePort Kidney Transporter 1.0 (Organ Recovery Systems). Separate devices were used for human and animal studies. 2 mL of perfusate was sampled at 45 minutes and 4 hours for each kidney. Perfusate was transferred to a cryogenic vial and stored at −20°C until thawed at room temperature, prepared and processed.
Sample preparation
NMR samples were prepared by mixing 150 µL of 400 mM (pH 7.0) phosphate buffer containing 2 mM TMSP [(3-trimethylsilyl)propionic-(2,2,3,3-d4)-acid sodium salt] with 390 µL of each perfusate sample and 60 µL of deuterium oxide (D2O) to reach a final phosphate buffer concentration of 100 mM and a final TMSP concentration of 500 µM. After mixing, the 600 µL samples were pipetted into NMR tubes and centrifuged to remove any air bubbles.
1H-NMR spectra were acquired using a Bruker AVII 500 MHz spectrometer equipped with a 5 mm inverse Cryoprobe. The sample temperature was set to 300 K, excitation sculpting was used to suppress the water resonance [24]. One-dimensional spectra were acquired using a 6 kHz spectral width, 32768 data points, 4 s relaxation delay and 128 transients. Matching was manual prior to acquisition of first sample and each sample was automatically shimmed (1D-TopShim) to a TMSP line width of less than 1 Hz prior to acquisition. Samples with a TMSP line width >1 Hz were acquired again after manual shimming where the TMSP half height line width was shimmed below 1 Hz. Total experimental time was approximately 15 minutes per sample.
All data sets were processed using the MATLAB based MetaboLab software [25]. Data sets were zero filled to 65536 data points. An exponential line broadening of 0.3 Hz was applied before Fourier transformation. The chemical shift axis was calibrated by referencing the TMSP signal to 0 ppm. Spectra were manually phase corrected and baseline correction using a spline before segmental alignment of all resonances using Icoshift [26]. Spectra were then exported into Bruker format.
Resultant spectra were examined using Chenomx 7.0 (ChenomxInc) profiling to identify metabolites and their concentrations, as illustrated in Fig. 1. Concentrations were corrected to compensate for the dilutional effect of the buffer.
Localised spectral plots for metabolites of interest with shaded figures illustrating metabolite quantification via best fit analysis using Chenomx metabolite database.
Statistical Methodology
Prior to analysis, the distribution of metabolites was examined. Where non-normality was detected, Log10-transformations were applied, after adding 1 to remove zero values. Repeated measures ANOVA models were then used to compare metabolite concentrations, both between pig and human samples, and between 45 minute and 4 hour timepoints. In addition to the main effect terms in the models, interactions were also included, in order to compare the rate of change over time in the metabolite concentrations between pig and human samples.
Data were reported as arithmetic means and 95% confidence intervals for the normally-distributed data. Where Log-transformations were used, the resulting summary statistics were back transformed, and reported as geometric means and 95% confidence intervals.
All analysis was performed using IBM SPSS 19 (IBM Corp. Armonk, NY), with p<0.05 deemed to be indicative of statistical significance.
Results
Metabolic support may be an important factor in the observed benefit of HMP compared with cold storage for preserving kidneys prior to transplantation. Experimental studies are needed to detail the metabolic activity of kidneys under various storage conditions, but the usage of healthy human kidneys for such research purposes is not justified.
This study seeks to ascertain whether the abundant and accessible porcine kidney can provide a reliable metabolic model for the human kidney during HMP.
Metabolite concentrations as determined from 1H-NMR spectra from 10 porcine kidneys were compared with 12 standard criteria cadaveric human kidneys, all of which were successfully transplanted with immediate graft function.
A spectral overlay analysis was performed for the mean spectra for pig and human samples at 45 minutes and 4 hours. There were similar profiles for both pig and human groups (Fig. 2). There were no metabolites consistently present in significant quantities that were not detected in the other group.
In total, 30 metabolites were identified in the perfusate of both pig and human kidneys during hypothermic machine perfusion. Of these, 6 (gluconate, mannitol, glucose, adenine, ribose and glutathione) were constituents of the original KPS-1 perfusion fluid. There was consumption of glutathione in both pig and human groups but no other significant interspecies or time effect differences for the other five metabolites present.
For the 24 metabolites present de novo (therefore likely produced by the kidney), there was an overall change over time for 12, with production of lactate, glycine, glutamate, hypoxanthine, alanine, 3-hydroxybutryate, inosine, N-phenylacetylglycine, leucine, valine, isoleucine and fumarate.
When concentrations were analysed according to species, there was no difference during HMP between pig and human kidneys for 16 metabolites as assessed using a repeated measures analysis. The rate of change of concentration for 3-hydroxybutyrate was greater in human kidneys compared to pig kidneys (0.017 to 0.040 mM vs 0.012 to 0.013 mM) (p<0.001). The vast majority of metabolites detected (29/30) demonstrated no difference in the rate of change between pig and human samples (Table 1, Fig. 3).
Discussion
The aim of this study was to determine whether or not the porcine kidney provides a reliable metabolic model for the human kidney, as assessed by 1H-NMR.
Whilst it is recognized that 1H-NMR can be used to detect metabolic changes present within the perfusates during HMP, this paper demonstrates that in both human and pig studies a significant amount of metabolic activity occurs. Some interspecies metabolite differences are evident but nevertheless, the similarity between the two groups is striking. This appears to validate porcine HMP as a valid metabolic model for human studies and would suggest that a defined optimal metabolic support protocol for HMP in a pig model would be translatable into clinical practice.
The majority of metabolites were present in similar concentrations in both species. For metabolites where concentration differences were observed, all but 3-hydroxybutryate had comparable rates of change in concentration for pig and human samples. This would imply that the active metabolic pathways during HMP in both human and pig kidneys are broadly comparable. The kidney cannot synthesise the ketone body 3-hydroxybutyrate to any significant extent but can consume it as an energy source and is likely to be more pronounced in stressful conditions such as hypothermia [27], [28]. Interspecies differences in the levels of the enzyme responsible for metabolising 3-hydroxybutyrate, 3-hydroxybutyrate dehydrogenase within the renal cortex and in plasma levels of 3-hydroxybutyrate have been reported and may account for this finding [29].
The pig kidneys were subjected to a warm ischaemia time of 14 minutes which is more prolonged than many Donation after Brain Death (DBD) human kidneys. However the cold ischaemic time for the pig organs (2 hours) was shorter than the human group in this study (mean 8 hr 40 min). There was also a significant age discrepancy between the pig and human organs, with the older human kidneys also likely subject to the global metabolic changes associated with brain death prior to retrieval including thyroid, catecholamine and glycaemic effects [30]–[35]. Such difference in retrieval conditions is likely to account for many of the interspecies differences found such as the trend towards higher levels of lactate in the human kidneys.
The authors acknowledge that the good quality standard criteria human kidneys in this study are not representative of many of the organs used in clinical practice. Indeed extended criteria organs may have most to gain from metabolic optimistion during machine perfusion and further studies would be of value. Whilst the number and concentration change of the metabolites in pig and human perfusates are comparable in this study, it lacks the power to detect small interspecies differences. Furthermore in 1-D spectra, metabolites with small single peaks can be obscured by more dominant signals from other metabolites with similar chemical shifts.
Perfusate analysis determines the concentration of metabolites in the extracellular environment of the kidney. Whilst the intracellular activity of many metabolites can be inferred from this, metabolomic analysis of kidney tissue would provide a more detailed account of the intracellular milieu and is a limitation of this study.
This study demonstrates that 1H-NMR spectroscopy profiles of perfusate samples for porcine and human kidneys during HMP are similar and implies that similar metabolic processes occur during preservation in the two species. This further validates the pig as a model for human transplantation and for HMP in particular.
Acknowledgments
This work was supported by a grant from University Hospital Birmingham charities trust. The authors would like to thank Peter Demuylder and Gunther Vanwezer at Organ Recovery systems for their help and support.
Author Contributions
Conceived and designed the experiments: JN AG MC NGI CL DAT ARR. Performed the experiments: JN AG TBS. Analyzed the data: JN AG TBS JH CL DAT. Contributed reagents/materials/analysis tools: JN AG CL JH. Wrote the paper: JN AG TBS. Paper Review: MC NGI JH CL DAT ARR.
References
- 1. Moers C, Smits JM, Maathuis MH, Treckmann J, van Gelder F, et al. (2009) Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med 360:7–19.
- 2. Cannon RM, Brock GN, Garrison RN, Smith JW, Marvin MR, et al. (2013) To pump or not to pump: a comparison of machine perfusion vs cold storage for deceased donor kidney transplantation. J Am Coll Surg 216:625–633 discussion 633–624.
- 3. Lodhi SA, Lamb KE, Uddin I, Meier-Kriesche HU (2012) Pulsatile pump decreases risk of delayed graft function in kidneys donated after cardiac death. Am J Transplant 12:2774–2780.
- 4. Kwiatkowski A, Wszola M, Kosieradzki M, Danielewicz R, Ostrowski K, et al. (2007) Machine perfusion preservation improves renal allograft survival. Am J Transplant 7:1942–1947.
- 5. Wight JP, Chilcott JB, Holmes MW, Brewer N (2003) Pulsatile machine perfusion vs. cold storage of kidneys for transplantation: a rapid and systematic review. Clin Transplant 17:293–307.
- 6. Shah AP, Milgrom DP, Mangus RS, Powelson JA, Goggins WC, et al. (2008) Comparison of pulsatile perfusion and cold storage for paired kidney allografts. Transplantation 86:1006–1009.
- 7. Matsuoka L, Shah T, Aswad S, Bunnapradist S, Cho Y, et al. (2006) Pulsatile perfusion reduces the incidence of delayed graft function in expanded criteria donor kidney transplantation. Am J Transplant 6:1473–1478.
- 8. Suarez JF, Riera L, Franco E, Ruiz R, Roig M, et al. (1999) Preservation of kidneys from marginal donors with pulsatile perfusion machine. Transplant Proc 31:2292–2293.
- 9. Sellers MT, Gallichio MH, Hudson SL, Young CJ, Bynon JS, et al. (2000) Improved outcomes in cadaveric renal allografts with pulsatile preservation. Clin Transplant 14:543–549.
- 10. Polyak MM, Arrington BO, Stubenbord WT, Boykin J, Brown T, et al. (2000) The influence of pulsatile preservation on renal transplantation in the 1990s. Transplantation 69:249–258.
- 11. Matsuno N, Kozaki K, Degawa H, Narumi Y, Suzuki N, et al. (2000) A useful predictor in machine perfusion preservation for kidney transplantation from non-heart-beating donors. Transplant Proc 32:173–174.
- 12. Kozaki K, Sakurai E, Uchiyama M, Matsuno N, Kozaki M, et al. (2000) Usefulness of high-risk renal graft conditioning: functional improvement of high-risk grafts by addition of reagents to continuous hypothermic perfusion preservation solution. Transplant Proc 32:164–166.
- 13. Fuller BJ, Lee CY (2007) Hypothermic perfusion preservation: the future of organ preservation revisited? Cryobiology 54:129–145.
- 14. Henry SD, Nachber E, Tulipan J, Stone J, Bae C, et al. (2012) Hypothermic machine preservation reduces molecular markers of ischemia/reperfusion injury in human liver transplantation. Am J Transplant 12:2477–2486.
- 15. Guy AJ, Nath J, Cobbold M, Ludwig C, Tennant DA, et al. (2014) Metabolomic Analysis of Perfusate During Hypothermic Machine Perfusion of Human Cadaveric Kidneys. Transplantation
- 16. Giraud S, Favreau F, Chatauret N, Thuillier R, Maiga S, et al. (2011) Contribution of large pig for renal ischemia-reperfusion and transplantation studies: the preclinical model. J Biomed Biotechnol 2011:532127.
- 17. Sachs DH (1994) The pig as a potential xenograft donor. Vet Immunol Immunopathol 43:185–191.
- 18. Hannon JP, Bossone CA, Wade CE (1990) Normal physiological values for conscious pigs used in biomedical research. Lab Anim Sci 40:293–298.
- 19. Swindle MM (2012) The development of swine models in drug discovery and development. Future Med Chem 4:1771–1772.
- 20. Bagul A, Hosgood SA, Kaushik M, Kay MD, Waller HL, et al. (2008) Experimental renal preservation by normothermic resuscitation perfusion with autologous blood. British Journal of Surgery 95:111–118.
- 21. Bon D, Claire B, Thuillier R, Hebrard W, Boildieu N, et al. (2014) Analysis of Perfusates During Hypothermic Machine Perfusion by NMR Spectroscopy: A Potential Tool for Predicting Kidney Graft Outcome. Transplantation
- 22. Merrifield CA, Lewis M, Claus SP, Beckonert OP, Dumas ME, et al. (2011) A metabolic system-wide characterisation of the pig: a model for human physiology. Mol Biosyst 7:2577–2588.
- 23. Nielsen KL, Hartvigsen ML, Hedemann MS, Laerke HN, Hermansen K, et al. (2014) Similar metabolic responses in pigs and humans to breads with different contents and compositions of dietary fibers: a metabolomics study. Am J Clin Nutr 99:941–949.
- 24. Hwang TL, Shaka AJ (1995) Water Suppression That Works - Excitation Sculpting Using Arbitrary Wave-Forms and Pulsed-Field Gradients. Journal of Magnetic Resonance Series A 112:275–279.
- 25.
Ludwig C, Gunther UL (2011) MetaboLab - advanced NMR data processing and analysis for metabolomics. Bmc Bioinformatics 12.
- 26. Savorani F, Tomasi G, Engelsen SB (2010) icoshift: A versatile tool for the rapid alignment of 1D NMR spectra. Journal of Magnetic Resonance 202:190–202.
- 27. Laffel L (1999) Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Res Rev 15:412–426.
- 28. Garber AJ, Menzel PH, Boden G, Owen OE (1974) Hepatic ketogenesis and gluconeogenesis in humans. J Clin Invest 54:981–989.
- 29. Koundakjian PP, Snoswell AM (1970) Ketone body and fatty acid metabolism in sheep tissues. 3-Hydroxybutyrate dehydrogenase, a cytoplasmic enzyme in sheep liver and kidney. Biochem J 119:49–57.
- 30. Smith M (2004) Physiologic changes during brain stem death–lessons for management of the organ donor. J Heart Lung Transplant 23:S217–222.
- 31. Barklin A, Larsson A, Vestergaard C, Kjaergaard A, Wogensen L, et al. (2008) Insulin alters cytokine content in two pivotal organs after brain death: a porcine model. Acta Anaesthesiol Scand 52:628–634.
- 32. Wood KE, Becker BN, McCartney JG, D′Alessandro AM, Coursin DB (2004) Care of the potential organ donor. N Engl J Med 351:2730–2739.
- 33. Bugge JF (2009) Brain death and its implications for management of the potential organ donor. Acta Anaesthesiol Scand 53:1239–1250.
- 34. Gramm HJ, Meinhold H, Bickel U, Zimmermann J, von Hammerstein B, et al. (1992) Acute endocrine failure after brain death? Transplantation 54:851–857.
- 35. Powner DJ, Hendrich A, Lagler RG, Ng RH, Madden RL (1990) Hormonal changes in brain dead patients. Crit Care Med 18:702–708.